Standard cross-validation conflates model selection with performance estimation, producing optimistically biased scores. When the same data that guides hyperparameter tuning is also used to report ...
Chimeric antigen receptor (CAR) T-cell therapy has revolutionized treatment for non-responsive or relapsing hematological malignancies, providing an intensive, personalized form of immunotherapy. It ...
Deepak Kilari, MD, shared his insights on recent trials in renal cell carcinoma presented at the 2026 ASCO Genitourinary Cancers Symposium. For oncologists navigating the rapidly evolving landscape of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results